Novo Nordisk A/S
NVO · Healthcare · $204.7B+2.07%
0
A · Solid Growth
Price
Score
$49.1239
$47.0083
Feb 10, 26May 12, 26
Quarterly Financials
RevenueOperating IncomeNet Income
3/'26
Revenue$96.8B+22.3%
Operating Income$59.6B+87.9%
Net Income$48.6B+80.6%
12/'25 vs prev quarter
Recent News
AI, Obesity Drugs, and Diagnostics Fuel Healthcare GrowthYesterdayNovo Nordisk: Flipping The ScriptYesterdayIs This News From Novo Nordisk a Warning for Eli Lilly Shareholders?2d agoOral Ozempic and Wegovy pills now available for same-day delivery on Amazon2d agoNovo Nordisk India Sales Jump After Price Cuts3d ago
Company Health
Operating Margin+45.3%
Cash on Hand$21.6B
PSR0.6x
PER1.7x
PBR1.0x
ROE+60.1%